Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-31 2024-12-31 true 2024-01-01 No description of principal activity The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.1 true false 1 false 13121089 2024-01-01 2024-12-31 13121089 2023-01-01 2023-12-31 13121089 2024-12-31 13121089 2023-12-31 13121089 c:Director1 2024-01-01 2024-12-31 13121089 d:CurrentFinancialInstruments 2024-12-31 13121089 d:CurrentFinancialInstruments 2023-12-31 13121089 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 13121089 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 13121089 d:ShareCapital 2024-12-31 13121089 d:ShareCapital 2023-12-31 13121089 d:RetainedEarningsAccumulatedLosses 2024-12-31 13121089 d:RetainedEarningsAccumulatedLosses 2023-12-31 13121089 c:OrdinaryShareClass1 2024-01-01 2024-12-31 13121089 c:OrdinaryShareClass1 2024-12-31 13121089 c:OrdinaryShareClass1 2023-12-31 13121089 c:OrdinaryShareClass2 2024-01-01 2024-12-31 13121089 c:OrdinaryShareClass2 2024-12-31 13121089 c:OrdinaryShareClass2 2023-12-31 13121089 c:FRS102 2024-01-01 2024-12-31 13121089 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 13121089 c:FullAccounts 2024-01-01 2024-12-31 13121089 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 13121089 6 2024-01-01 2024-12-31 13121089 e:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 13121089 SERENE SEDATION LTD UNAUDITED FINANCIAL STATEMENTS INFORMATION FOR FILING WITH THE REGISTRAR FOR THE YEAR ENDED 31 DECEMBER 2024
SERENE SEDATION LTD REGISTERED NUMBER: 13121089 BALANCE SHEET AS AT 31 DECEMBER 2024
|  | 2024 |  | 2023
Note |  | £ |  | £
Fixed assets |  |  |  |  |
Investments | 4 |  | 75,000 |  | 75,000
Creditors: amounts falling due within one year | 5 | (76,553) |  | (75,590) |
Net current liabilities |  |  | (76,553) |  | (75,590)
Total assets less current liabilities |  |  | (1,553) |  | (590)
Net liabilities |  |  | (1,553) |  | (590)
Capital and reserves |  |  |  |  |
Called up share capital | 6 |  | 100 |  | 100
Profit and loss account |  |  | (1,653) |  | (690)
|  |  | (1,553) |  | (590)
The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf on 16 September 2025.
................................................ M I H Kassam
Director
The notes on pages 2 to 3 form part of these financial statements. Page 1
SERENE SEDATION LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
1. | General information
Serene Sedation Ltd is a private company, limited by shares, incorporated in England and Wales with the registration number 13121089. The address of the registered office is Anglia House 6 Central Avenue, St Andrews Business Park, Thorpe St Andrew, Norwich, Norfolk, NR7 0HR. The financial statements are presented in sterling, which is the functional currency of the company, and rounded to the nearest £. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The following principal accounting policies have been applied:
| 2.2 | Going concern
The director has, at the time of approving the financial statements, a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they adopt a going concern basis of accounting in preparing the financial statements. The director has considered a period of 12 months from the balance sheet date.
| 2.3 | Valuation of investments
Investments in subsidiaries are measured at cost less accumulated impairment.
| 2.4 | Creditors
Short-term creditors are measured at the transaction price.
| 2.5 | Financial instruments
The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments. The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102. Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
3. | Employees
| The average monthly number of employees, including directors, during the year was 1 (2023 - 1).
Page 2
SERENE SEDATION LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
4. | Fixed asset investments
|  | Unlisted investments
|  | £
| Cost or valuation |
| At 1 January 2024 | 75,000
| At 31 December 2024 | 75,000
5. | Creditors: Amounts falling due within one year
|  |  |  |  | 2024 | 2023
|  |  |  |  | £ | £
| Other creditors | 76,053 | 75,590
| Accruals and deferred income | 500 | -
|  | 76,553 | 75,590
6. | Share capital
|  |  |  |  | 2024 | 2023
|  |  |  |  | £ | £
|  | Allotted, called up and fully paid |  |
|  | 51 (2023 - 51) Ordinary A shares of £1.00 each | 51 | 51
|  | 49 (2023 - 49) Ordinary B shares of £1.00 each | 49 | 49
|  |  | 100 | 100
7. | Related party transactions
| At 1 January 2023 the Company owed the director £75,590, during the year expenses were paid of £463, leaving a balance of £76,053 due to them as at 31 December 2024.
Page 3